<DOC>
	<DOCNO>NCT02108886</DOCNO>
	<brief_summary>Preterm birth major public health problem , actual treatment efficient . The purpose study test efficiency combine use Montelukast Nifedipine treat preterm labor . Investigators aim reduce uterine contraction efficiently use Nifedipine .</brief_summary>
	<brief_title>Pilot Study Testing New Strategy Management Spontaneous Preterm Birth</brief_title>
	<detailed_description>An inflammatory process involve 60 % preterm birth . Moreover , investigator previously demonstrate enzyme lipoxygenase pathway present uterine smooth muscle , additive tocolytic effect obtain combine use Montelukast Nifedipine . Methods : This double-blinded randomized control assay perform CHUS two group 50 woman . Women select admitted preterm labor gestational age 26 34 week . The first group receive Nifedipine 48 hour , describe standard protocol CHUS , addition 10 mg Montelukast per day , delivery 35 week pregnancy . The second group receive Nifedipine 48 hour , describe standard protocol CHUS , addition placebo per day , delivery 35 week pregnancy . Cervical secretion urine sample admission , one week every two week treatment .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>woman 2434 week pregnancy indication tocolysis preterm labor 26 34 week pregnancy minor patient patient obstetrical pathology twin pregnancy fetal distress severe congenital fetal malformation antiphospholipid syndrome lupus gestational diabetes nephropathy congenital heart disease obvious cause infection associate prematurity patient viral infection ( HIV , hepatitis ) patient already treat Montelukast</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>preterm labor</keyword>
	<keyword>montelukast</keyword>
	<keyword>uterine contraction</keyword>
</DOC>